-
Mount Sinai discovery could affect kidney failure treatment
TORONTO | Researchers Dr. Susan Quaggin and Dr. Tony Pawson at Mount Sinai Hospital’s Samuel Lunenfeld Research Institute have made a discovery relating to the effects of a vital signalling protein in the kidney. It could affect drug therapies and treatment for the more than 30,000 Canadians who suffer from kidney failure.